Syn-BMT challenged both STAT1-intact and STAT1-deficient recipients with the same pre-transplant TBI conditioning and overall experimental procedures, while allo-BMT also introduced immune-mediated intestinal injury due to GVHD (Fig. 2a). The gene discussed is STAT1; the disease is graft versus host disease.